LONDONAstraZeneca PLC on Monday rejected what US peer Pfizer Inc said was its final increased offer seeming to scuttle what would have been a huge transAtlantic pharmaceutical merger and sending the British companys shares plummeting as much as  Late Sunday Pfizer made a final offer for AstraZeneca valued at roughly  billion or   a share with a  cash component  AstraZeneca
  